Merck Aktie
123,10
EUR
+0,85
EUR
+0,70
%
Kursziele der Merck-Aktie in EUR
Das durchschnittliche Kursziel beinhaltet alle Analysen eines Analysten und nicht nur die jeweils aktuellste Analyse, die im Chart dargestellt wird.
Diese Analysten bewerten die Merck-Aktie
| Analyst | Kursziel | Abstand Kursziel | Datum | |
|---|---|---|---|---|
| JP Morgan Chase & Co. | 190,00 EUR | +53,78% | 10:31 Uhr | |
| UBS AG | 180,00 EUR | +45,69% | 25.04.2025 | |
| Goldman Sachs Group Inc. | 169,00 EUR | +36,79% | 16.04.2025 | |
| Bernstein Research | 168,00 EUR | +35,98% | 10.04.2025 | |
| DZ BANK | - | - | 01.04.2025 | |
| Deutsche Bank AG | 174,00 EUR | +40,83% | 07.03.2025 | |
| Jefferies & Company Inc. | 180,00 EUR | +45,69% | 14.11.2024 | |
| Barclays Capital | 195,00 EUR | +57,83% | 01.08.2024 |
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| 3M Co. | 0 | 0 | 0 | - | - |
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| AstraZeneca PLC | 6 | 3 | 0 | 137,65 GBP | +30,77% |
| BASF | 5 | 4 | 2 | 52,14 EUR | +14,64% |
| Bayer | 1 | 8 | 0 | 25,03 EUR | +8,92% |
| BB Biotech AG | 0 | 0 | 0 | - | - |
| Beiersdorf AG | 8 | 1 | 2 | 144,20 EUR | +18,88% |
| Biotest AG Vz. | 0 | 0 | 0 | - | - |
| Bristol-Myers Squibb Co. | 0 | 0 | 0 | - | - |
| Clorox Co., The | 0 | 0 | 0 | - | - |
| Colgate-Palmolive Co. | 0 | 0 | 0 | - | - |
| Eli Lilly | 1 | 0 | 0 | 994,00 USD | +13,83% |
| Gilead Sciences Inc. | 0 | 0 | 0 | - | - |
| GSK PLC Registered Shs | 2 | 5 | 1 | 16,53 GBP | +17,32% |
| H. B. Fuller Co. | 0 | 0 | 0 | - | - |
| H&R GmbH & Co. KGaA | 0 | 1 | 0 | - | - |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| L'Oréal S.A. (L'Oreal, L Oreal) | 3 | 5 | 2 | 362,78 EUR | -4,09% |
| LANXESS AG | 3 | 3 | 4 | 28,00 EUR | +5,26% |
| Merck Co. | 0 | 0 | 0 | - | - |
| Merck KGaA | 7 | 1 | 0 | 179,43 EUR | +45,23% |
| Novartis AG | 3 | 5 | 1 | 99,75 CHF | +6,80% |
| Pfizer Inc. | 3 | 3 | 0 | 29,20 USD | +27,15% |
| Procter & Gamble Co. | 1 | 0 | 0 | 177,00 USD | +9,54% |
| Reckitt Benckiser Plc | 3 | 7 | 0 | 57,10 GBP | +21,90% |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Sanofi S.A. | 6 | 3 | 0 | 115,12 EUR | +23,68% |
| STADA | 0 | 0 | 0 | - | - |
| Takeda Pharmaceutical Co. Ltd. | 0 | 0 | 0 | - | - |
| Unilever plc | 6 | 1 | 3 | 48,11 GBP | - |
| WACKER CHEMIE AG | 6 | 2 | 0 | 93,86 EUR | +32,85% |